Britton Trabert, MS, PhD

Research Interests

  • Ovarian Cancer
  • Endometrial Cancer
  • Cancer Survivorship
  • Etiologic Heterogeneity

Languages

  • English

Academic Information

  • Departments: Obstetrics/Gynecology - Assistant Professor
  • Divisions: Gynecologic Oncology

Academic Bio

Britton Trabert, MS, PhD is a reproductive and cancer epidemiologist and Assistant Professor of Obstetrics and Gynecology at the University of Utah School of Medicine and a Huntsman Cancer Institute Investigator in the Cancer Control and Population Sciences Research Program. Dr. Trabert’s research focuses on the epidemiology and etiologic heterogeneity of gynecologic malignances, specifically ovarian and endometrial cancers. Her research program includes classic and molecular epidemiologic research approaches to identify strategies for disease prevention or earlier disease detection. Dr. Trabert is PI of a Department of Defense Investigator Initiated Research Award in the Ovarian Cancer Research Program to evaluate the association between frequent aspirin use and ovarian cancer risk.

In her most recent position, Dr. Trabert led a multi-disciplinary research program in the Metabolic Epidemiology Branch of the Division of Cancer Epidemiology and Genetics at the National Cancer Institute (NCI). She joined the NCI Division of Cancer Epidemiology and Genetics (DCEG) as a Sallie Rosen Kaplan Postdoctoral Fellow in 2009, was promoted to research fellow in 2011, and was appointed as an Earl Stadtman Tenure-Track Investigator in 2014. Dr. Trabert completed her doctoral degree in the Department of Epidemiology at the University of Washington School of Public Health and was the inaugural predoctoral fellow on the T32 Reproductive, Pediatric, and Perinatal Epidemiology Training Grant. She received her MS in Biostatistics from the University of Michigan School of Public Health where she actively participated in the interdepartmental concentration in Reproductive and Women’s Health and her MSPH in Epidemiology from the Rollins School of Public Health at Emory University.

Education History

Type School Degree
Research Fellow National Institutes of Health, National Cancer Institute
Hormonal and Reproductive Epidemiology Branch
Postdoctoral Research Fellow
Postdoctoral Fellowship National Institutes of Health, National Cancer Institute
Hormonal and Reproductive Epidemiology Branch
Postdoctoral Fellow
Certification University of Washington
Public Health Genetics
Certificate
Fellowship University of Washington
Reproductive, Pediatric & Perinatal Epidemiology
Predoctoral Fellow
Professional Medical University of Washington
Epidemiology
Ph.D.
Certification University of Michigan
Reproductive and Women's Health
Certificate
Graduate Training University of Michigan
Biostatistics
M.S.
Graduate Training Emory University
Epidemiology
M.S.P.H.
Undergraduate Iowa State University
Biology
B.S.

Selected Publications

Journal Article

  1. Trabert B, Hathaway CA, Rice MS, Rimm EB, Sluss PM, Terry KL, Zeleznik OA, Tworoger SS (2021). Ovarian cancer risk in relation to blood cholesterol and triglycerides. (Epub ahead of print) Cancer Epidemiol Biomarkers Prev.
  2. Virani S, Baiocchi G, Bowtell D, Cabasag CJ, Cho KR, Fortner RT, Fujiwara K, Kim JW, Kbel M, Kurtz JE, Levine DA, Menon U, Norquist BM, Pharoah PDP, Sood AK, Tworoger ST, Wentzensen N, Chanock SJ, Brennan P, Trabert B (2021). Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research. Carcinogenesis, 42(6), 785-793.
  3. Hurwitz LM, Pinsky PF, Trabert B (2021). General population screening for ovarian cancer. Lancet, 397(10290), 2128-2130.
  4. King LA, Michels KA, Graubard BI, Trabert B (2021). Trends in oral contraceptive and intrauterine device use among reproductive-aged women in the US from 1999 to 2017. Cancer Causes Control, 32(6), 587-595.
  5. Michels KA, Geczik AM, Bauer DC, Brinton LA, Buist DSM, Cauley JA, Dallal CM, Falk RT, Hue TF, Lacey JV Jr, LaCroix AZ, Tice JA, Xu X, Trabert B (2021). Endogenous Progestogens and Colorectal Cancer Risk among Postmenopausal Women. Cancer Epidemiol Biomarkers Prev, 30(6), 1100-1105.
  6. Hurwitz LM, Michels KA, Cook MB, Pfeiffer RM, Trabert B (2020). Associations between daily aspirin use and cancer risk across strata of major cancer risk factors in two large U.S. cohorts. Cancer Causes Control, 32(1), 57-65.
  7. Hurwitz LM, Pinsky PF, Huang WY, Freedman ND, Trabert B (2020). Aspirin use and ovarian cancer risk using extended follow-up of the PLCO Cancer Screening Trial. Gynecol Oncol, 159(2), 522-526.
  8. Trabert B, Sherman ME, Kannan N, Stanczyk FZ (2018). Progesterone and Breast Cancer. Endocr Rev, 41(2).
  9. Eldridge RC, Wentzensen N, Pfeiffer RM, Brinton LA, Hartge P, Guillemette C, Kemp TJ, Pinto LA, Trabert B (2020). Endogenous estradiol and inflammation biomarkers: potential interacting mechanisms of obesity-related disease. Cancer Causes Control, 31(4), 309-320.
  10. Trabert B, Bauer DC, Buist DSM, Cauley JA, Falk RT, Geczik AM, Gierach GL, Hada M, Hue TF, Lacey JV Jr, LaCroix AZ, Tice JA, Xu X, Dallal CM, Brinton LA (2020). Association of Circulating Progesterone With Breast Cancer Risk Among Postmenopausal Women. JAMA Netw Open, 3(4), e203645.
  11. Trabert B, Troisi R, Grotmol T, Ekbom A, Engeland A, Gissler M, Glimelius I, Madanat-Harjuoja L, Srensen HT, Tretli S, Gulbech Ording A, Bjrge T (2019). Associations of pregnancy-related factors and birth characteristics with risk of endometrial cancer: A Nordic population-based case-control study. Int J Cancer, 146(6), 1523-1531.
  12. Trabert B, Tworoger SS, OBrien KM, Townsend MK, Fortner RT, Iversen ES, Hartge P, White E, Amiano P, Arslan AA, Bernstein L, Brinton LA, Buring JE, Dossus L, Fraser GE, Gaudet MM, Giles GG, Gram IT, Harris HR, Bolton JH, Idahl A, Jones ME, Kaaks R, Kirsh VA, Knutsen SF, Kvaskoff M, Lacey JV, Lee IM, Milne RL, Onland-Moret NC, Overvad K, Patel AV, Peters U, Poynter JN, Riboli E, Robien K, Rohan TE, Sandler DP, Schairer C, Schouten LJ, Setiawan VW, Swerdlow AJ, Travis RC, Trichopoulou A, van den Brandt PA, Visvanathan K, Wilkens LR, Wolk A, Zeleniuch-Jacquotte A, Wentzensen N, Ovarian Cancer Cohort Consortium OC3 (2020). The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3). Cancer Res, 80(5), 1210-1218.
  13. Hada M, Oh H, Fan S, Falk RT, Geller B, Vacek P, Weaver D, Shepherd J, Wang J, Fan B, Herschorn S, Brinton LA, Xu X, Sherman ME, Trabert B, Gierach GL (2020). Relationship of Serum Progesterone and Progesterone Metabolites with Mammographic Breast Density and Terminal Ductal Lobular Unit Involution among Women Undergoing Diagnostic Breast Biopsy. J Clin Med, 9(1).
  14. Michels KA, McNeel TS, Trabert B (2019). Metabolic syndrome and risk of ovarian and fallopian tube cancer in the United States: An analysis of linked SEER-Medicare data. Gynecol Oncol, 155(2), 294-300.
  15. Trabert B, Coburn SB, Falk RT, Manson JE, Brinton LA, Gass ML, Kuller LH, Rohan TE, Pfeiffer RM, Qi L, Stefanick ML, Wentzensen N, Anderson GL, Xu X (2019). Circulating estrogens and postmenopausal ovarian and endometrial cancer risk among current hormone users in the Women's Health Initiative Observational Study. Cancer Causes Control, 30(11), 1201-1211.
  16. Trabert B, Michels KA, Anderson GL, Brinton LA, Falk RT, Geczik AM, Harris HR, Pan K, Pfeiffer RM, Qi L, Rohan T, Wentzensen N, Xu X (2019). Circulating androgens and postmenopausal ovarian cancer risk in the Women's Health Initiative Observational Study. Int J Cancer, 145(8), 2051-2060.
  17. Michels KA, Brinton LA, Wentzensen N, Pan K, Chen C, Anderson GL, Pfeiffer RM, Xu X, Rohan TE, Trabert B (2019). Postmenopausal Androgen Metabolism and Endometrial Cancer Risk in the Women's Health Initiative Observational Study. JNCI Cancer Spectr, 3(3), pkz029.
  18. Lu J, Trabert B, Liao LM, Pfeiffer RM, Michels KA (2018). Dietary intake of nutrients involved in folate-mediated one-carbon metabolism and risk for endometrial cancer. Int J Epidemiol, 48(2), 474-488.
  19. Falk RT, Manson JE, Barnabei VM, Anderson GL, Brinton LA, Rohan TE, Cauley JA, Chen C, Coburn SB, Pfeiffer RM, Reding KW, Sarto GE, Wentzensen N, Chlebowski RT, Xu X, Trabert B (2018). Estrogen metabolism in menopausal hormone users in the women's health initiative observational study: Does it differ between estrogen plus progestin and estrogen alone? Int J Cancer, 144(4), 730-740.
  20. Trabert B, Waterboer T, Idahl A, Brenner N, Brinton LA, Butt J, Coburn SB, Hartge P, Hufnagel K, Inturrisi F, Lissowska J, Mentzer A, Peplonska B, Sherman ME, Wills GS, Woodhall SC, Pawlita M, Wentzensen N (2018). Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations. J Natl Cancer Inst, 111(2), 129-136.
  21. Trabert B, Poole EM, White E, Visvanathan K, Adami HO, Anderson GL, Brasky TM, Brinton LA, Fortner RT, Gaudet M, Hartge P, Hoffman-Bolton J, Jones M, Lacey JV, Larsson SC, Mackenzie GG, Schouten LJ, Sandler DP, OBrien K, Patel AV, Peters U, Prizment A, Robien K, Setiawan VW, Swerdlow A, van den Brandt PA, Weiderpass E, Wilkens LR, Wolk A, Wentzensen N, Tworoger SS, Ovarian Cancer Cohort Consortium OC3 (2018). Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium. J Natl Cancer Inst, 111(2), 137-145.
  22. Hada M, Edin ML, Hartge P, Lih FB, Wentzensen N, Zeldin DC, Trabert B (2018). Prediagnostic Serum Levels of Fatty Acid Metabolites and Risk of Ovarian Cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev, 28(1), 189-197.
  23. Coburn SB, Stanczyk FZ, Falk RT, McGlynn KA, Brinton LA, Sampson J, Bradwin G, Xu X, Trabert B (2018). Comparability of serum, plasma, and urinary estrogen and estrogen metabolite measurements by sex and menopausal status. Cancer Causes Control, 30(1), 75-86.
  24. Samimi G, Trabert B, Geczik AM, Duggan MA, Sherman ME (2018). Population Frequency of Serous Tubal Intraepithelial Carcinoma (STIC) in Clinical Practice Using SEE-Fim Protocol. JNCI Cancer Spectr, 2(4), pky061.
  25. Michels KA, Brinton LA, Pfeiffer RM, Trabert B (2017). Oral Contraceptive Use and Risks of Cancer in the NIH-AARP Diet and Health Study. Am J Epidemiol, 187(8), 1630-1641.
  26. Ghazarian AA, Rusner C, Trabert B, Braunlin M, McGlynn KA, Stang A (2018). Testicular cancer among US men aged 50 years and older. Cancer Epidemiol, 55, 68-72.
  27. Trabert B, Coburn SB, Mariani A, Yang HP, Rosenberg PS, Gierach GL, Wentzensen N, Cronin KA, Sherman ME (2017). Reported Incidence and Survival of Fallopian Tube Carcinomas: A Population-Based Analysis From the North American Association of Central Cancer Registries. J Natl Cancer Inst, 110(7), 750-757.
  28. Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A, Siegel RL (2018). Ovarian cancer statistics, 2018. CA Cancer J Clin, 68(4), 284-296.
  29. Michels KA, Pfeiffer RM, Brinton LA, Trabert B (2018). Modification of the Associations Between Duration of Oral Contraceptive Use and Ovarian, Endometrial, Breast, and Colorectal Cancers. JAMA Oncol, 4(4), 516-521.
  30. Trabert B, Aarestrup J, Ulrich LG, Wentzensen N, Srensen TIA, Baker JL (2018). Birth weight and the risk of histological subtypes of ovarian and endometrial cancers: Results from the Copenhagen School Health Records Register. Gynecol Oncol, 148(3), 547-552.
  31. Samimi G, Trabert B, Duggan MA, Robinson JL, Coa KI, Waibel E, Garcia E, Minasian LM, Sherman ME (2017). Processing of fallopian tube, ovary, and endometrial surgical pathology specimens: A survey of U.S. laboratory practices. Gynecol Oncol, 148(3), 515-520.
  32. Playdon MC, Coburn SB, Moore SC, Brinton LA, Wentzensen N, Anderson G, Wallace R, Falk RT, Pfeiffer R, Xu X, Trabert B (2017). Alcohol and oestrogen metabolites in postmenopausal women in the Women's Health Initiative Observational Study. Br J Cancer, 118(3), 448-457.
  33. Oh H, Arem H, Matthews CE, Wentzensen N, Reding KW, Brinton LA, Anderson GL, Coburn SB, Cauley JA, Chen C, Goodman D, Pfeiffer RM, Falk RT, Xu X, Trabert B (2017). Sitting, physical activity, and serum oestrogen metabolism in postmenopausal women: the Women's Health Initiative Observational Study. Br J Cancer, 117(7), 1070-1078.
  34. Coburn SB, Bray F, Sherman ME, Trabert B (2017). International patterns and trends in ovarian cancer incidence, overall and by histologic subtype. Int J Cancer, 140(11), 2451-2460.
  35. Brinton LA, Thistle JE, Liao LM, Trabert B (2017). Epidemiology of vulvar neoplasia in the NIH-AARP Study. Gynecol Oncol, 145(2), 298-304.
  36. Cannioto RA, Trabert B, Poole EM, Schildkraut JM (2017). Ovarian cancer epidemiology in the era of collaborative team science. Cancer Causes Control, 28(5), 487-495.
  37. Oh H, Coburn SB, Matthews CE, Falk RT, LeBlanc ES, Wactawski-Wende J, Sampson J, Pfeiffer RM, Brinton LA, Wentzensen N, Anderson GL, Manson JE, Chen C, Zaslavsky O, Xu X, Trabert B (2017). Anthropometric measures and serum estrogen metabolism in postmenopausal women: the Women's Health Initiative Observational Study. Breast Cancer Res, 19(1), 28.
  38. Trabert B, Eldridge RC, Pfeiffer RM, Shiels MS, Kemp TJ, Guillemette C, Hartge P, Sherman ME, Brinton LA, Black A, Chaturvedi AK, Hildesheim A, Berndt SI, Safaeian M, Pinto L, Wentzensen N (2016). Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial. Int J Cancer, 140(3), 600-610.
  39. Trabert B (2016). Body Powder and Ovarian Cancer Risk-What Is the Role of Recall Bias? Cancer Epidemiol Biomarkers Prev, 25(10), 1369-1370.
  40. Wentzensen N, Poole EM, Trabert B, White E, Arslan AA, Patel AV, Setiawan VW, Visvanathan K, Weiderpass E, Adami HO, Black A, Bernstein L, Brinton LA, Buring J, Butler LM, Chamosa S, Clendenen TV, Dossus L, Fortner R, Gapstur SM, Gaudet MM, Gram IT, Hartge P, Hoffman-Bolton J, Idahl A, Jones M, Kaaks R, Kirsh V, Koh WP, Lacey JV Jr, Lee IM, Lundin E, Merritt MA, Onland-Moret NC, Peters U, Poynter JN, Rinaldi S, Robien K, Rohan T, Sandler DP, Schairer C, Schouten LJ, Sjholm LK, Sieri S, Swerdlow A, Tjonneland A, Travis R, Trichopoulou A, van den Brandt PA, Wilkens L, Wolk A, Yang HP, Zeleniuch-Jacquotte A, Tworoger SS (2016). Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium. J Clin Oncol, 34(24), 2888-98.
  41. Brinton LA, Trabert B, Anderson GL, Falk RT, Felix AS, Fuhrman BJ, Gass ML, Kuller LH, Pfeiffer RM, Rohan TE, Strickler HD, Xu X, Wentzensen N (2016). Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women. Cancer Epidemiol Biomarkers Prev, 25(7), 1081-9.
  42. Trabert B, Brinton LA, Anderson GL, Pfeiffer RM, Falk RT, Strickler HD, Sliesoraitis S, Kuller LH, Gass ML, Fuhrman BJ, Xu X, Wentzensen N (2016). Circulating Estrogens and Postmenopausal Ovarian Cancer Risk in the Women's Health Initiative Observational Study. Cancer Epidemiol Biomarkers Prev, 25(4), 648-56.
  43. Trabert B, Xu X, Falk RT, Guillemette C, Stanczyk FZ, McGlynn KA (2015). Assay reproducibility of serum androgen measurements using liquid chromatography-tandem mass spectrometry. J Steroid Biochem Mol Biol, 155(Pt A), 56-62.
  44. Brinton LA, Moghissi KS, Scoccia B, Lamb EJ, Trabert B, Niwa S, Ruggieri D, Westhoff CL (2015). Effects of fertility drugs on cancers other than breast and gynecologic malignancies. Fertil Steril, 104(4), 980-988.
  45. Trabert B, Falk RT, Stanczyk FZ, McGlynn KA, Brinton LA, Xu X (2015). Reproducibility of an assay to measure serum progesterone metabolites that may be related to breast cancer risk using liquid chromatography-tandem mass spectrometry. Horm Mol Biol Clin Investig, 23(3), 79-84.
  46. Wentzensen N, Trabert B (2015). Hormone therapy: short-term relief, long-term consequences. Lancet, 385(9980), 1806-8.
  47. Trabert B, Chen Z, Kannan K, Peterson CM, Pollack AZ, Sun L, Buck Louis GM (2014). Persistent organic pollutants (POPs) and fibroids: results from the ENDO study. J Expo Sci Environ Epidemiol, 25(3), 278-85.
  48. Trabert B, Wentzensen N, Felix AS, Yang HP, Sherman ME, Brinton LA (2015). Metabolic syndrome and risk of endometrial cancer in the united states: a study in the SEER-medicare linked database. Note: Recognized as one of 20 most frequently cited CEBP articles of 2015. Cancer Epidemiol Biomarkers Prev, 24(1), 261-7.
  49. Trabert B, Chen J, Devesa SS, Bray F, McGlynn KA (2014). International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973-2007. Andrology, 3(1), 4-12.
  50. Trabert B, Falk RT, Figueroa JD, Graubard BI, Garcia-Closas M, Lissowska J, Peplonska B, Fox SD, Brinton LA (2014). Urinary bisphenol A-glucuronide and postmenopausal breast cancer in Poland. Cancer Causes Control, 25(12), 1587-93.
  51. Trabert B, Pinto L, Hartge P, Kemp T, Black A, Sherman ME, Brinton LA, Pfeiffer RM, Shiels MS, Chaturvedi AK, Hildesheim A, Wentzensen N (2014). Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial. Gynecol Oncol, 135(2), 297-304.
  52. Trabert B, Ness RB, Lo-Ciganic WH, Murphy MA, Goode EL, Poole EM, Brinton LA, Webb PM, Nagle CM, Jordan SJ, Australian Ovarian Cancer Study Group Australian Cancer Study Ovarian Cancer, Risch HA, Rossing MA, Doherty JA, Goodman MT, Lurie G, Kjr SK, Hogdall E, Jensen A, Cramer DW, Terry KL, Vitonis A, Bandera EV, Olson S, King MG, Chandran U, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Wu AH, Pearce CL, Pike MC, Berchuck A, Schildkraut JM, Wentzensen N, Ovarian Cancer Association Consortium (2014). Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst, 106(2), djt431.
  53. Trabert B, Lamb EJ, Scoccia B, Moghissi KS, Westhoff CL, Niwa S, Brinton LA (2013). Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort. Fertil Steril, 100(6), 1660-6.
  54. Trabert B, Zugna D, Richiardi L, McGlynn KA, Akre O (2013). Congenital malformations and testicular germ cell tumors. Int J Cancer, 133(8), 1900-4.
  55. Wartko P, Sherman ME, Yang HP, Felix AS, Brinton LA, Trabert B (2013). Recent changes in endometrial cancer trends among menopausal-age U.S. women. Cancer Epidemiol, 37(4), 374-7.
  56. Trabert B, Graubard BI, Erickson RL, Zhang Y, McGlynn KA (2013). Second to fourth digit ratio, handedness and testicular germ cell tumors. Early Hum Dev, 89(7), 463-6.
  57. Brinton LA, Trabert B, Shalev V, Lunenfeld E, Sella T, Chodick G (2013). In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services. Fertil Steril, 99(5), 1189-96.
  58. Persson EC, Schwartz LM, Park Y, Trabert B, Hollenbeck AR, Graubard BI, Freedman ND, McGlynn KA (2013). Alcohol consumption, folate intake, hepatocellular carcinoma, and liver disease mortality. Cancer Epidemiol Biomarkers Prev, 22(3), 415-21.
  59. Trabert B, Wentzensen N, Yang HP, Sherman ME, Hollenbeck AR, Park Y, Brinton LA (2012). Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk? Int J Cancer, 132(2), 417-26.
  60. Yang HP, Wentzensen N, Trabert B, Gierach GL, Felix AS, Gunter MJ, Hollenbeck A, Park Y, Sherman ME, Brinton LA (2012). Endometrial cancer risk factors by 2 main histologic subtypes: the NIH-AARP Diet and Health Study. Am J Epidemiol, 177(2), 142-51.
  61. Sahasrabuddhe VV, Gunja MZ, Graubard BI, Trabert B, Schwartz LM, Park Y, Hollenbeck AR, Freedman ND, McGlynn KA (2012). Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J Natl Cancer Inst, 104(23), 1808-14.
  62. Trabert B, Graubard BI, Nyante SJ, Rifai N, Bradwin G, Platz EA, McQuillan GM, McGlynn KA (2012). Relationship of sex steroid hormones with body size and with body composition measured by dual-energy X-ray absorptiometry in US men. Cancer Causes Control, 23(12), 1881-91.
  63. Murphy MA, Trabert B, Yang HP, Park Y, Brinton LA, Hartge P, Sherman ME, Hollenbeck A, Wentzensen N (2012). Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review. Cancer Causes Control, 23(11), 1839-52.
  64. Trabert B, Wentzensen N, Yang HP, Sherman ME, Hollenbeck A, Danforth KN, Park Y, Brinton LA (2012). Ovarian cancer and menopausal hormone therapy in the NIH-AARP diet and health study. Br J Cancer, 107(7), 1181-7.
  65. Yang HP, Trabert B, Murphy MA, Sherman ME, Sampson JN, Brinton LA, Hartge P, Hollenbeck A, Park Y, Wentzensen N (2011). Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health Study. Int J Cancer, 131(4), 938-48.
  66. Trabert B, Longnecker MP, Graubard BI, Klebanoff MA, Stanczyk FZ, McGlynn KA (2011). Placental characteristics as a proxy measure of serum hormone and protein levels during pregnancy with a male fetus. Cancer Causes Control, 22(5), 689-95.

Letter

  1. Michels KA, Trabert B (2018). Oral Contraceptive Progestin and Estrogen Use and Increases in Breast, Ovarian, and Endometrial Cancers-Reply. [Letter to the editor]. JAMA Oncol, 4(11), 1623-1624.
  2. Trabert B, Chodick G, Shalev V, Sella T, Longnecker MP, McGlynn KA (2013). Gestational diabetes and the risk of cryptorchidism and hypospadias. [Letter to the editor]. Epidemiology, 25(1), 152-3.